AI Care Management recognized as essential component of national healthcare modernization effort
SAN FRANCISCO, July 31, 2025 /PRNewswire/ — Ellipsis Health, creator of Sage, the emotionally intelligent AI care manager, has been selected as a key partner in the Health Tech Ecosystem, a cornerstone initiative of the Centers for Medicare and Medicaid Services (CMS) digital modernization program. The company, represented by CEO Mainul Mondal, joined CMS Administrator Dr. Mehmet Oz, federal leadership, and a select group of leading health systems, payors, and innovators, in Washington, D.C. to tackle developments in healthcare that serve the benefit of all patients.
As part of the CMS program, Ellipsis Health has pledged to develop:
The company’s AI care manager, Sage, already conducts patient interactions, demonstrating the empathetic engagement and clinical rigor this initiative seeks to advance.
“This initiative goes beyond technological advancement; It demonstrates how artificial intelligence can strengthen human healthcare delivery,” said Mainul Mondal, CEO of Ellipsis Health. “We applaud CMS for assembling this Health Tech Ecosystem. True progress happens when innovative organizations unite behind patient-first principles.”
About Ellipsis Health
Ellipsis Health is an AI healthcare company transforming care management through an emotionally intelligent AI voice agent. Powered by its patented Empathy Engine, the company’s AI Care Manager, Sage, expands provider capacity, streamlines workflows, and elevates patient engagement, allowing clinical staff to operate at the top of their license. Ellipsis Health is trusted by top-tier healthcare organizations, including leading providers and payers, to deliver AI solutions proficient at handling patients with complex physical, behavioral and social needs that drive the majority of healthcare costs. For more information, visit www.ellipsishealth.com.
SOURCE Ellipsis Health
Registration Link for Phio's Presentation on Thursday, January 22 at 1:45 PM ETKing of Prussia,…
WASHINGTON, D.C. / ACCESS Newswire / January 15, 2026 / The American Medical Informatics Association…
CID-103 is a potential best-in-class, anti-CD38 monoclonal antibody; binds to unique CD38 epitopeAMR is a…
Multi-year wins underscore sustained specialty-first innovation, workflow depth, and revenue-cycle performance at scale TAMPA, FLORIDA…
First of its kind in the UK as medical cannabis patients get on-demand legal support…
NOTTINGHAM, UK / ACCESS Newswire / January 15, 2026 / First of its kind in…